Skip to main content
SpringerLink
Log in

Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro

  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

The frequently occurring alteration of ganglioside expression in tumor cells has been implicated to play a role in the uncontrolled growth of these cells; antibodies to such gangliosides might affect tumor cell growth. We have studied the effect of IgM monoclonal antibodies to two glioma-associated gangliosides, GD3 and GM2, on cell proliferation of four human glioma cell lines and one renal tumor cell line. Of the two anti-ganglioside antibodies tested, only the anti-GD3 antibody resulted in a significant (p<0.005) inhibition of cell proliferation as measured by thymidine incorporation and Brd-U labeling, after 24[emsp4 ]h incubation. The effect was not dependent on any serum factor and no increased cell death was observed. All cell lines contained higher or similar amounts of GM2 than GD3, and both antigens were shown to be expressed on the cell surface and accessible to antibodies. The selective effect of anti-GD3 antibodies as contrasted to the inactivity of anti-GM2 antibodies suggests a possible role for ganglioside GD3 in tumor cell proliferation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hakomori S-I, Aberrant glycosylation in tumors and tumorassociated carbohydrate antigens, Adv Cancer Res 52, 257–331 (1989).

    Google Scholar 

  2. Yates AJ, Thompson DK, Boesel CP, Albrightson C, Hart RW, Lipid composition of human neural tumors, J Lipid Res 20, 428–36 (1979).

    Google Scholar 

  3. Fredman P, Gangliosides in human malignant gliomas, New Trends in Ganglioside Research 14, 151–61 (1988).

    Google Scholar 

  4. von Holst H, Nygren C, Boström K, Collins VP, Fredman P, The presence of fetal ganglioside antigens, 3'-isoLM1 and 3'6'-isoLD1, in both glioma tissue and surrounding areas from human brain, Acta Neurochir 139, 141–5 (1997).

    Google Scholar 

  5. Svennerholm L, Boström K, Fredman P, MÅnsson J-E, Rosengren B, Rynmark B-M, Human brain gangliosides: developmental changes from early fetal stage to advanced age, Biochim Biophys Acta 1005, 109–17 (1989).

    Google Scholar 

  6. Fredman P, MÅnsson J-E, Bigner SH, Wikstrand CJ, Bigner DD, Svennerholm L, Gangliosides in the human glioma cell line U-118 MG grown in culture or as xenografts in nude rats, Biochim Biophys Acta 1045, 239–44 (1990).

    Google Scholar 

  7. Hakomori S-I, Igarashi Y, Gangliosides and glycosphingolipids as modulators of cell growth, adhesion, and transmembrane signaling, Adv Lipid Res 25, 147–62 (1993).

    Google Scholar 

  8. Bjerkvig R, Engebraaten O, Laerum OD, Fredman P, Svennerholm L, Vrionis FD, Wikstrand CJ, Bigner DD, Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line, Cancer Res 51, 4643–8 (1991).

    Google Scholar 

  9. Houghton AN, Mintzer D, Cordon-Cardo C, Welt S, Fliegel B, Vadhan S, Carswell E, Melamed MR, Oettgen HF, Old LJ, Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma, Proc Natl Acad Sci USA 82, 1242–6 (1985).

    Google Scholar 

  10. Dippold WG, Bernhard H, Dienes HP, zum Buschenfelde K-HM, Treatment of patients with malignant melanoma by monoclonal ganglioside antibodies, Eur J Cancer Clin Oncol 24, S65–7 (1988).

    Google Scholar 

  11. Dippold WG, Knuth A, zum Buschenfelde K-HM, Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody, Cancer Res 44, 806–10 (1984).

    Google Scholar 

  12. Katano M, Irie RF, Human monoclonal antibody to tumor-associated ganglioside GD2: suppressed growth of human melanoma in nude mice, Immunol Lett 8, 169–74 (1984).

    Google Scholar 

  13. Cheung N-KV, Lazarus H, Miraldi FD, Abramowsky CR, Kallick S, Saarinen UM, Spitzer T, Strandjord SE, Coccia PF, Berger NA, Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma, J Clin Oncol 5, 1430–40 (1987).

    Google Scholar 

  14. Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum O-D, Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro, Cancer Res 50, 6039–44 (1990).

    Google Scholar 

  15. Engebraaten O, Bjerkvig R, Pedersen P-H, Laerum OD, Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro, Int J Cancer 53, 209–14 (1993).

    Google Scholar 

  16. Pedersen P-H, Ness GO, Engebraaten O, Bjerkvig R, Lillehaug JR, Laerum OD, Heterogeneous response to the growth factors (EGF, PDGF(bb), TGF-α, bFGF, IL-2) on glioma spheroid growth, migration and invasion, Int J Cancer 56, 255–61 (1994).

    Google Scholar 

  17. Yates AJ, Saqr HE, van Brocklyn J, Ganglioside modulation of the PDGF receptor, J Neurooncol 24, 65–73 (1995).

    Google Scholar 

  18. Kasahara K, Watanabe Y, Yamamoto T, Sanai Y, Association of Src family tyrosine kinase Lyn with ganglioside GD3 in rat brain, J Biol Chem 272, 29947–53 (1997).

    Google Scholar 

  19. Hakomori S-I, Handa K, Iwabuchi K, Yamamura S, Prinetti A, New insights in glycosphingolipid function: “glycosignaling domain,” a cell surface assembly of glycosphingolipids with signal transducer molecules, involved in cell adhesion coupled with signaling, Glycobiology 8, xi–xix (1998).

    Google Scholar 

  20. Slagel DE, Dittmer JC, Wilson CM, Lipid composition of human glial tumour and adjacent brain, J Neurochem 14, 789–98 (1967).

    Google Scholar 

  21. Kostic’ D, Bucheit F, Gangliosides in human brain tumours, Life Sci 9, 589–96 (1970).

    Google Scholar 

  22. Traylor TD, Hogan EL, Gangliosides of human cerebral astrocytomas, J Neurochem 34, 126–31 (1980).

    Google Scholar 

  23. Eto Y, Shinoda S, Gangliosides and neutral glycosphingolipids in human brain tumors: specificity and their significance, Adv Exp Med Biol 152, 279–90 (1982).

    Google Scholar 

  24. Berra B, Gaini SM, Riboni L, Correlation between ganglioside distribution and histological grading of human astrocytomas, Int J Cancer 36, 363–66 (1985).

    Google Scholar 

  25. Fredman P, von Holst H, Collins VP, Ammar A, Dellheden B, Wahren B, Granholm L, Svennerholm L, Potential ganglioside antigens associated with human gliomas, Neurol Res 8, 123–6 (1986).

    Google Scholar 

  26. Fredman P, von Holst H, Collins VP, Dellheden B, Svennerholm L, Expression of gangliosides GD3 and 3'-isoLM1 in autopsy brains from patients with malignant tumors, J Neurochem 60, 99–105 (1993).

    Google Scholar 

  27. Rosengren B, MÅnsson J-E, Svennerholm L, Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease? J Neurochem 49, 834–40 (1987).

    Google Scholar 

  28. MÅnsson J-E, Fredman P, Bigner DD, Molin K, Rosengren B, Friedman HS, Svennerholm L, Characterization of new gangliosides of the lactotetraose series in murine xenografts of a human glioma cell line, FEBS Lett 201, 109–13 (1986a).

    Google Scholar 

  29. MÅnsson J-E, Mo H, Egge H, Svennerholm L, Trisialosyllactosylceramide (GT3) is a ganglioside of human lung, FEBS Lett 196, 259–62 (1986b).

    Google Scholar 

  30. Karlsson G, MÅnsson J-E, Wikstrand C, Bigner D, Svennerholm L, Characterization of the binding epitope of the monoclonal antibody DMAb-1 to ganglioside GM2, BBA 1043, 267–72 (1990).

    Google Scholar 

  31. Fredman P, MÅnsson J-E, Wikstrand CJ, Vrionis FD, Rynmark B-M, Bigner DD, Svennerholm L, A new ganglioside of the lactotetraose series, Gal-NAc-3'-isoLM1, detected in human meconium, J Biol Chem 264, 12122–25 (1989).

    Google Scholar 

  32. He X, Wikstrand CJ, Fredman P, MaÊnsson J-E, Svennerholm L, Bigner DD, GD3 expression by cultured human tumor cells of neuroectodermal origin, Acta Neuropathol 79, 317–25 (1989).

    Google Scholar 

  33. Premkumar E, Potter M, Singer PA, Sklar MD, Synthesis, surface deposition, and secretion of immunoglobulins by Abelson virustransformed lymphosarcoma cell lines, Cell 6, 149–59 (1975).

    Google Scholar 

  34. Brismar T, Collins VP, Inward rectifying potassium channels in human malignant glioma cells, Brain Res 480, 249–58 (1989).

    Google Scholar 

  35. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP, In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors, J Natl Cancer Inst 51, 1417–23 (1973).

    Google Scholar 

  36. Wikstrand CJ, Bigner SH, Bigner DD, Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies, Cancer Res 43, 3327–34 (1983).

    Google Scholar 

  37. Pontén J, MacIntyre EH, Long term culture of normal and neoplastic human glia, Acta Path Microbiol Scandinav 74, 465–86 (1968).

    Google Scholar 

  38. Bullard DE, Schold SC, Bigner SH, Bigner DD, Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines, J Neuropathol Exp Neurol 40, 410–27 (1981).

    Google Scholar 

  39. Miyao N, Tsukamoto T, Kumamoto Y, Establishment of three human renal cell carcinoma cell lines (SMKT-R-1, SMKT-R-2, and SMKT-R-3) and their characters, Urol Res 17, 317–24 (1989).

    Google Scholar 

  40. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC, Measurement of protein using bicinchoninic acid, Anal Biochem 150, 76–85 (1985).

    Google Scholar 

  41. Mosmann T, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol Methods 65, 55–63 (1983).

    Google Scholar 

  42. Miltenburger HG, Sachse G, Schliermann M, S-phase cell detection with a monoclonal antibody, Dev Biol Stand 66, 91–9 (1987).

    Google Scholar 

  43. Dean PN, Dolbeare F, Gratzner H, Rice GC, Gray JW, Cell-cycle analysis using a monoclonal antibody to BrdUrd, Cell Tissue Kinet 17, 427–36 (1984).

    Google Scholar 

  44. Gratzner HG, Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine: a new reagent for detection of DNA replication, Science 218, 474–5 (1982).

    Google Scholar 

  45. Muir D, Varon S, Manthorpe M, An enzyme-linked immunosorbent assay for bromodeoxyuridine incorporation using fixed microcultures, Anal Biochem 185, 377–82 (1990).

    Google Scholar 

  46. Svennerholm L, Fredman P, A procedure for the quantitative isolation of brain gangliosides, Biochim Biophys Acta 617, 97–109 (1980).

    Google Scholar 

  47. Davidsson P, Fredman P, Collins PV, von Holst H, MÅnsson J-E, Svennerholm L, Ganglioside composition in human meningiomas, J Neurochem 53, 705–9 (1989).

    Google Scholar 

  48. Fredman P, Nilsson O, Tayot J-L, Svennerholm L, Separation of gangliosides on a new type of anion-exchange resin, Biochim Biophys Acta 618, 42–52 (1980).

    Google Scholar 

  49. Svennerholm L, MÅnsson J-E, Li Y-T, Isolation and structural determination of a novel ganglioside, a disialosylpentahexosylceramide from human brain, J Biol Chem 248, 740–2 (1973).

    Google Scholar 

  50. Holmgren J, Lindblad M, Fredman P, Svennerholm L, Myrvold H, Comparison of receptors for Cholera and Escherichia coli enterotoxins in human intestine, Gastroenterology 89, 27–35 (1985).

    Google Scholar 

  51. Hakomori S, Cell density-dependent changes of glycolipid concentrations in fibroblasts, and loss of this response in virus-transformed cells, PNAS 67, 1741–7 (1970).

    Google Scholar 

  52. Sakiyama H, Gross SK, Robbins PW, Glycolipid synthesis in normal and virus-transformed hamster cell lines, PNAS 69, 872–6 (1972).

    Google Scholar 

  53. Birklé S, Gao L, Zeng G, Yu RK, Down-regulation of GD3 ganglioside and its O-acetylated derivative by stable transfection with antisense vector against GD3-synthase gene expression in hamster melanoma cells: Effect on cellular growth, melanogenesis, and dendricity, J Neurochem 74, 547–54 (2000).

    Google Scholar 

  54. Gillard BK, Clement R, Colucci-Guyon E, Babinet C, Schwarzmann G, Taki T, Kasama T, Marcus DM, Decreased synthesis of glycosphingolipids in cells lacking vimentin intermediate filaments, Exp Cell Res 242(2), 561–72 (1998).

    Google Scholar 

  55. Wikstrand CJ, Fredman P, Svennerholm L, Bigner DD, Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 and 3'6'-isoLD1 in central nervous system tumors in vitro and in Monoclonal anti-GD3 antibodies 725 vivo using epitope-defined monoclonal antibodies, Prog Brain Res 101, 213–23 (1994).

    Google Scholar 

  56. Masserini M, Palestini P, Pitto M, Glycolipid-enriched caveolae and caveolae-like domains in the nervous system, J Neurochem 73, 1–11 (1999).

    Google Scholar 

  57. IUPAC-IUB, Commission on Biochemical Nomenclature (CBN): The nomenclature of lipids, Lipids 12, 455–68 (1977).

    Google Scholar 

  58. Svennerholm L, Chromatographic separation of human brain gangliosides, J Neurochem 10, 613–23 (1963).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Göteborg University, Sahlgrenska University Hospital/Mölndal, Institute of Clinical Neuroscience, Section of Experimental Neuroscience, S-431 80, Mölndal, Sweden

    Kristina M. Hedberg, Birgitta Dellheden & Pam Fredman

  2. Department of Pathology, Duke University Medical Center, Durham, N.C., 27710, USA

    Carol J. Wikstrand

Authors
  1. Kristina M. Hedberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Birgitta Dellheden
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carol J. Wikstrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pam Fredman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hedberg, K.M., Dellheden, B., Wikstrand, C.J. et al. Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro. Glycoconj J 17, 717–726 (2000). https://doi.org/10.1023/A:1011026823362

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011026823362

Search

Navigation